| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $63.1M | +5.7% |
| Cost of Revenue | $13.7M | +13.7% |
| Gross Profit | $49.4M | +3.6% |
| R&D Expense | $29.9M | +44.0% |
| SG&A Expense | $34.0M | -9.4% |
| Operating Income | -$45.9M | -13.9% |
| Pre-tax Income | -$44.6M | -14.7% |
| Income Tax | -$3.4M | -810.5% |
| Net Income | -$41.2M | -4.6% |
| EPS (Basic) | -$1.39 | +9.2% |
| EPS (Diluted) | -$1.39 | +9.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.0M | -54.1% |
| Accounts Receivable | $9.7M | +5.4% |
| Current Assets | $46.1M | -57.1% |
| Total Assets | $122.6M | -13.8% |
| Current Liabilities | $38.4M | +11.4% |
| Total Liabilities | $47.7M | +12.8% |
| Stockholders' Equity | $75.0M | -25.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.9M | -71.5% |
| Capital Expenditures | $618K | +22.4% |
| Investing Cash Flow | $33.7M | +150.7% |
| Financing Cash Flow | -$2.2M | -102.2% |
| Free Cash Flow | -$34.5M | -70.2% |